Cargando…
Fine-tuning anti-tumor immunotherapies via stochastic simulations
BACKGROUND: Anti-tumor therapies aim at reducing to zero the number of tumor cells in a host within their end or, at least, aim at leaving the patient with a sufficiently small number of tumor cells so that the residual tumor can be eradicated by the immune system. Besides severe side-effects, a key...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303725/ https://www.ncbi.nlm.nih.gov/pubmed/22536975 http://dx.doi.org/10.1186/1471-2105-13-S4-S8 |